The Dual Identity of the 50% Rule: A Comprehensive Analysis of the Delaware R&D Tax Credit (30 Del. C. § 2070)

I. Executive Summary: The Dual Meaning of the 50% Factor

The “Former Tax Liability Limit (50%)” refers to an archaic restriction repealed in 2017, which means the Delaware Research and Development (R&D) credit is now fully refundable as a cash payment.

However, the 50% figure persists today as a mandatory statutory calculation factor used by general taxpayers to determine the amount of the credit generated when electing the Alternative Simplified Credit (ASC) method under Delaware law.

This distinction is fundamental for strategic tax planning: Delaware eliminated constraints on utilizing the approved credit, transforming it into a direct cash subsidy, but retained a statutory factor that restricts the initial calculation size for large corporations choosing the ASC method. Understanding this duality is paramount for maximizing the benefit derived from 30 Del. C. § 2070.1

II. Legislative Analysis: The Repeal of the Former Tax Liability Limit

The history of the 50% tax liability limit demonstrates Delaware’s strategic evolution of its R&D incentive from a modest tax offset to a powerful, fully refundable tool designed to foster technological growth. Addressing the query regarding the “Former Tax Liability Limit (50%)” requires establishing its obsolete nature due to landmark legislative action.

A. The Pre-2017 Constraint: The 50% Limit on Qualified Tax Liability

Prior to 2017, the Delaware R&D tax credit operated under significant structural constraints that limited its efficacy, particularly for R&D-intensive companies that were not yet profitable. The core restriction was statutory: an earlier version of the law, specifically a deleted subsection (c) of $\S 2070$, explicitly dictated that the calculated R&D credit “shall not exceed in any one taxable year 50% of the qualified tax liability for that taxable year”.3

This mechanism meant the credit could only offset up to half of the state income tax liability for a given year. The credit was applied against the taxpayer’s qualified tax liability, which principally involves corporate income tax liabilities.1 If a company lacked sufficient tax liability, the value of the credit was diminished, restricting the immediate benefit.5 Unused credits could only be carried forward for up to 15 succeeding taxable years.6

In addition to this utilization cap, the Delaware R&D credit was subject to a total statewide credit cap. If total applications for the credit exceeded $5 million in a given year, credits would be prorated accordingly.5 These limitations severely restricted the immediate cash flow advantages for early-stage firms, inhibiting the state’s ability to attract and retain high-growth enterprises in sectors like biotechnology or advanced manufacturing, which often generate significant R&D expenses well before achieving profitability.2

B. The Transformation: The Delaware Commitment to Innovation Act (2016)

The landscape for R&D incentives in Delaware was fundamentally altered by the passage of the Delaware Commitment to Innovation Act of 2016 (80 Del. Laws, c. 207, $\S 2$), with provisions becoming effective for tax periods beginning after December 31, 2016.3

This legislation was a pivotal move, explicitly removing both the restrictive statewide application cap and the former 50% limitation on utilizing the credit against qualified tax liability.5 The central component of this statutory overhaul was the introduction of full refundability. Under the current law, 30 Del. C. $\S 2070(\text{c})$, if a taxpayer cannot use the entire approved R&D tax credit amount to offset its qualified tax liability, the “unused credit shall be paid to it in the nature of a tax refund”.7

This shift transformed the credit from a tax offset into a direct economic subsidy. Since the approved credit amount is now paid out as cash regardless of whether the taxpayer has any liability, the 50% cap on utilization against qualified tax liability is functionally irrelevant. The move demonstrates a deliberate state policy choice to accelerate R&D investment by providing a vital, non-dilutive source of working capital.2 Delaware is recognized as the only state in the country that combines a zero-expenditure cap with a fully refundable tax credit, a unique competitive advantage for innovation.5

The historical and current functions of the 50% figure are contrasted below:

Table I: Former Tax Liability Limit vs. Current Calculation Factor (30 Del. C. § 2070)

III. Statutory Guidance: Where the 50% Calculation Factor Lives Today

While the old usage limit has been abolished, the number 50% retains a critical—albeit different—function within the R&D tax credit statute. It is the mandatory multiplication factor used in one of the two elective methods for calculating the credit amount itself, as governed by 30 Del. C. $\S 2070(\text{a})(1)$.

A. The Two Elective Calculation Methods

A Delaware taxpayer must make an annual election, choosing between two primary methods to determine the size of their available state R&D credit. This election is explicitly independent of the determination made for the federal R&D tax credit.1

The two methods are:

1. Method 1: The Base Amount Method: This method calculates the credit as $10\%$ of the excess of the taxpayer’s total Delaware Qualified Research and Development Expenses (QREs) for the taxable year over the taxpayer’s Delaware Base Amount.1
2. Method 2: The Alternative Simplified Credit (ASC) Method (The 50% Factor Method): This method calculates the credit based on the taxpayer’s federal R&D credit amount, utilizing the Alternative Simplified Credit (ASC) methodology found in Internal Revenue Code (IRC) $\S 41(\text{c})(5)$.1

B. Focus on Method 2: The 50% Calculation Factor for General Taxpayers

For any taxpayer that does not meet the definition of a “small business,” 30 Del. C. $\S 2070(\text{a})(1)(2)$ requires that the state credit be equal to 50% of Delaware’s apportioned share of the taxpayer’s hypothetical federal R&D tax credit calculated using the ASC method.1

This statutory requirement establishes a cap on the magnitude of the credit a large company can generate via the ASC method. The calculation involves two main steps:

1. Calculating Apportionment: Delaware employs an apportionment mechanism to ensure the incentive only reflects R&D activity conducted within the state’s borders. Delaware’s apportioned share of the federal credit is determined by multiplying the theoretical federal ASC credit (calculated using federal definitions and methodology) by the Apportionment Ratio.1 The ratio is defined as:
   
   $$\text{Apportionment Ratio} = \frac{\text{Delaware Qualified R\&D Expenses}}{\text{Total Qualified R\&D Expenses (All States)}}$$
   
   The Division of Revenue (DOR) forms, such as the older versions of Form 2070AC/2071AC, guide taxpayers through this precise calculation, requiring them to divide Delaware QREs by Total QREs.9
2. Applying the 50% Factor: Once the Delaware-apportioned share of the federal ASC is determined, that resulting amount is multiplied by the statutory 50% factor to arrive at the final Delaware R&D credit amount.1

This structure means that the effective state credit rate, derived from the federal ASC methodology, is functionally halved for large entities choosing this option. This constraint necessitates careful annual modeling by corporate tax directors. For multi-state companies, the Method 2 calculation requires accurate tracking of both in-state QREs and total QREs across all states to correctly compute the apportionment ratio, which directly influences the calculated credit magnitude.1 Companies that neglect the requirement for accurate apportionment risk incorrect application of the 50% factor and subsequent scrutiny by the DOR.

IV. Enhanced Opportunities for Small Businesses: The 100% Factor

The Delaware statute includes robust provisions designed to specifically accelerate growth and incentivize investment among smaller innovative companies, providing a significant exception to the general 50% factor.

A. Defining a Small Business

For the purposes of the R&D tax credit, the Delaware statute defines a “small business” as any taxpayer with average annual gross receipts that do not exceed the applicable threshold, which is currently $20,000,000.1 This definition is based on the methodology outlined in IRC $\S 41(\text{c})(1)(\text{B})$.1 Importantly, taxpayers must satisfy this gross receipts test regardless of the method they choose for calculating their federal R&D tax credit.1

B. The 100% Substitution Rule and Enhanced Rates

Delaware provides enhanced credit calculation rates for these small businesses:

• Method 2 Enhancement (ASC): In the case of a small business electing Method 2, 30 Del. C. $\S 2070(\text{a})(2)$ mandates substituting “100%” for “50%” in the calculation of Delaware’s apportioned share of the federal ASC credit.1 This effectively doubles the calculated credit amount compared to a large corporation performing the exact same R&D activities in Delaware, maximizing the incentive for small entities.
• Method 1 Enhancement (Base Amount): If a small business opts for Method 1, the percentage applied to the excess QREs over the base amount is adjusted from 10% to 20%.1

By granting a 100% factor and an enhanced 20% rate, Delaware exhibits a clear legislative preference for Small and Medium Enterprises (SMEs).11 This policy aims to ensure the state incentive is maximally impactful for those companies most likely to generate high-paying jobs and foster long-term in-state development. The 100% substitution often proves to be the most advantageous strategic choice for eligible small businesses, positioning the Delaware R&D credit as a powerful driver of liquidity.

V. State Revenue Office Guidance and Compliance Procedures

The Delaware Division of Revenue (DOR) maintains oversight for the administration and compliance of the R&D tax credit (30 Del. C. $\S\S 2070-2075$).2 Adherence to the DOR’s procedural guidance is essential for successfully claiming the credit.

A. Division of Revenue Administration and Forms

The DOR requires that any taxpayer electing to qualify for the Delaware R&D tax credit must first receive approval from the Division of Revenue.8

The application and reporting procedures involve specific forms and deadlines:

1. Form 2070AC/2071AC (Application): This form, used for requesting the credit, must be submitted to the Division of Revenue by September 15th following the end of the taxable year in which the qualified R&D expenses were incurred.5 A copy of the federal research credit Form 6765 must be attached to the application, confirming that the R&D activities meet federal qualification standards (IRC $\S 41$).5 The instructions on these forms, such as older revisions of Form 2070AC/2071AC, explicitly detail the steps for calculating the credit, including the multiplication of the apportioned federal credit by the 50% factor (for Method B, the ASC method).9
2. Form 700 (Delaware Income Tax Credit Schedule): Upon receiving approval for the credit amount determined via Form 2070AC/2071AC, the taxpayer must transfer the approved amount to the appropriate line on Delaware Form 700.5

B. Application and Refundability Mandate

The approved R&D credit is applied against the taxpayer’s “qualified tax liability for the taxable year in which the qualified research and development expenses were taken into account for purposes of Delaware income taxation”.4 For corporate taxpayers, this primarily involves offsetting corporate income taxes.2

Crucially, the DOR guidance reinforces the statutory mandate of full refundability. Unused tax credits are paid out directly to the taxpayer in the form of a tax refund.2 This mandate confirms that the former 50% limit on tax utilization is entirely obsolete. The taxpayer realizes 100% of the calculated credit amount (whether calculated using the 50% factor for large firms or the 100% factor for small firms).

The requirement for independent election of the state credit calculation, despite requiring the federal Form 6765, means taxpayers must proactively model both state Methods (10% or 20% on excess QREs, or 50% or 100% of apportioned ASC) annually to determine the most advantageous path.1

VI. Illustrative Example: Applying the 50% Calculation Factor

This detailed example illustrates how a large, multi-state corporation applies the 50% calculation factor when electing the Alternative Simplified Credit (ASC) Method (Method 2), and how the current full refundability negates the former 50% tax liability limit.

A. Case Study Parameters

A large multi-state corporation (“InnovateCo”) conducts R&D across several jurisdictions, including Delaware. InnovateCo’s average annual gross receipts exceed $20 million, classifying it as a general taxpayer subject to the 50% factor.1

Financial Data for Tax Year 2023:

• Federal R&D Tax Credit Equivalent (ASC Calculation): $\$500,000$ (The theoretical federal credit calculated using IRC $\S 41(\text{c})(5)$ methodology).
• Total Qualified R&D Expenses (All States): $\$10,000,000$
• Delaware Qualified R&D Expenses (In-State QREs): $\$7,500,000$
• Delaware Qualified Tax Liability (Before Credit): $\$250,000$

B. Detailed Step-by-Step Calculation (Method 2: ASC)

InnovateCo chooses Method 2 (ASC) for its Delaware filing. The calculation follows the guidance in 30 Del. C. $\S 2070(\text{a})(1)(2)$:

Table II: Calculation of Delaware R&D Credit Using the 50% ASC Factor (General Taxpayer)

C. Final Application and Refund Analysis

InnovateCo’s approved Delaware R&D credit is $187,500. This credit is applied against its qualified Delaware tax liability of $\$250,000$.

• Tax Liability: $\$250,000$
• Applied Credit: $\$187,500$
• Remaining Tax Due: $\$62,500$

Demonstrating the Repeal of the Former 50% Tax Liability Limit:

If InnovateCo had only generated a Delaware Qualified Tax Liability of $\$100,000$ (instead of $\$250,000$), the comparison against the repealed law is stark:

• Current Law (Post-2017): InnovateCo applies the full $\$187,500$ credit. The liability of $\$100,000$ is erased, and the remaining unused credit of $\$87,500$ ( $\$187,500 – \$100,000$) is paid directly to InnovateCo as a tax refund.2
• Former Law (Pre-2017): Under the repealed 50% tax liability limit, the credit utilization would have been capped at $50\%$ of the $\$100,000$ liability, or $\$50,000$. The remaining $\$137,500$ of the calculated credit would have been unusable in the current year and required to be carried forward (up to 15 years).3

The current system ensures that the entire calculated credit of $\$187,500$ is realized by the company, whether through tax offsets or cash refunds.

VII. Conclusions and Strategic Recommendations

The confusion surrounding the Delaware R&D credit’s 50% rule stems from the historical repeal of a tax utilization cap concurrent with the retention of a calculation factor. The analysis confirms that the Former Tax Liability Limit (50%) is defunct, replaced by a robust, fully refundable incentive system. The remaining 50% is simply a mandatory factor applied to the apportioned federal ASC amount for large corporations.

For Delaware businesses engaging in R&D, these factors lead to two strategic conclusions:

1. Liquidity is Guaranteed: The state’s commitment to full refundability ensures that the R&D tax credit serves as a vital source of working capital, especially for low-liability or pre-profit entities. Tax planning can proceed assuming 100% realization of the calculated credit amount.
2. Mandatory Modeling of Both Methods: For general taxpayers, the 50% calculation factor in Method 2 (ASC) significantly reduces the potential credit compared to the full 100% granted to small businesses. Taxpayers must annually model both Method 1 (10% of excess QREs over the base amount) and Method 2 (50% of apportioned federal ASC) to determine which calculation method yields the higher credit.1
3. Apportionment Rigor is Key: Given that the 50% factor is applied to the apportioned share, multi-state corporations must ensure meticulous documentation proving the proportion of their Qualified Research Expenses performed specifically within Delaware. Inaccurate apportionment renders the entire calculation susceptible to adjustment by the Delaware Division of Revenue.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/